Intra-Cellular Therapies, Inc. Human Resources Contracts & Agreements
55 Contracts & Agreements
- Bonus & Incentive Agreements (16 contracts)
- Compensation Agreements (9)
- Consulting Agreements (1)
- Employment Agreements (15)
- Non-Competition Agreements (13)
- Separation Agreements (1)
- Form of Amended and Restated Employee Proprietary Information, Inventions, and Non-Competition Agreement of Intra-Cellular Therapies, Inc. with each executive officer (Filed With SEC on October 30, 2024)
- Consulting Agreement, dated as of August 2, 2024, by and between Intra-Cellular Therapies, Inc. and Lawrence J. Hineline (Filed With SEC on August 7, 2024)
- Separation Agreement, dated as of August 2, 2024, by and between Intra-Cellular Therapies, Inc. and Lawrence J. Hineline (Filed With SEC on August 7, 2024)
- Employee Proprietary Information, Inventions, and Non-Competition Agreement, effective as of August 12, 2024, by and between Intra-Cellular Therapies, Inc. and Sanjeev Narula (Filed With SEC on August 7, 2024)
- Employment Agreement, effective as of August 12, 2024, by and between Intra-Cellular Therapies, Inc. and Sanjeev Narula (Filed With SEC on August 7, 2024)
- Amended and Restated 2018 Equity Incentive Plan (Filed With SEC on June 18, 2024)
- Form of Performance (Filed With SEC on May 7, 2024)
- Non-Employee Director Compensation Policy, as amended (Filed With SEC on May 7, 2024)
- Non-Employee Director Compensation Policy, as amended (Filed With SEC on May 4, 2023)
- Non-Employee Director Compensation Policy, as amended (Filed With SEC on May 10, 2022)
- Employee Proprietary Information, Inventions, Inventions, and Non-Competition Agreement effective as of September 12, 2018 by and between Suresh Durgam, M.D. and Intra-Cellular... (Filed With SEC on March 1, 2022)
- Employment Agreement effective as of September 12, 2018 by and between Suresh Durgam, M.D. and Intra-Cellular Therapies, Inc (Filed With SEC on March 1, 2022)
- Non-Employee Director Compensation Policy, as amended (Filed With SEC on August 9, 2021)
- Employment Agreement effective as of September 12, 2018 by and between Suresh Durgam, M.D. and Intra-Cellular Therapies, Inc (Filed With SEC on February 25, 2021)
- Form of Director Restricted Stock Unit Agreement under the Amended and Restated 2018 Equity Incentive Plan (Filed With SEC on August 10, 2020)
- Form of Restricted Stock Unit Agreement under the Amended and Restated 2018 Equity Incentive Plan (Filed With SEC on August 10, 2020)
- Form of Director Stock Option Agreement under the Amended and Restated 2018 Equity Incentive Plan (Filed With SEC on August 10, 2020)
- Form of Stock Option Agreement under the Amended and Restated 2018 Equity Incentive Plan (Filed With SEC on August 10, 2020)
- Amended and Restated 2018 Equity Incentive Plan (Filed With SEC on May 28, 2020)
- Non-Employee Director Compensation Policy, as amended (Filed With SEC on March 2, 2020)
- Employee Proprietary Information, Inventions, Inventions, and Non-Competition Agreement effective as of December 10, 2018 by and between Mark Neumann and Intra-Cellular Therapies,... (Filed With SEC on February 27, 2019)
- Employment Agreement effective as of October 15, 2018 by and between Mark Neumann and Intra-Cellular Therapies, Inc (Filed With SEC on February 27, 2019)
- Non-Employee Director Compensation Policy, as Amended (Filed With SEC on August 2, 2018)
- Form of Director Restricted Stock Unit Agreement under the 2018 Equity Incentive Plan (Filed With SEC on June 21, 2018)
- Form of Restricted Stock Unit Agreement under the 2018 Equity Incentive Plan (Filed With SEC on June 21, 2018)
- Form of Director Stock Option Agreement under the 2018 Equity Incentive Plan (Filed With SEC on June 21, 2018)
- Form of Stock Option Agreement under the 2018 Equity Incentive Plan (Filed With SEC on June 21, 2018)
- Intra-Cellular Therapies, Inc. 2018 Equity Incentive Plan (Filed With SEC on June 21, 2018)
- Non-Employee Director Compensation Policy, as amended (Filed With SEC on March 1, 2018)
- Employee Proprietary Information, Inventions, Inventions, and Non-Competition Agreement effective as of November 13, 2017 by and between Andrew Satlin, M.D. and Intra-Cellular... (Filed With SEC on March 1, 2018)
- Employment Agreement effective as of November 13, 2017 by and between Andrew Satlin, M.D. and Intra-Cellular Therapies, Inc (Filed With SEC on March 1, 2018)
- AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENT (Filed With SEC on November 9, 2016)
- AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENT (Filed With SEC on November 9, 2016)
- AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENT (Filed With SEC on November 9, 2016)
- INTRA-CELLULAR THERAPIES, INC. NON-EMPLOYEE DIRECTOR COMPENSATION POLICY (adopted June 30, 2014; amended March 30, 2016) (Filed With SEC on April 28, 2016)
- INTRA-CELLULAR THERAPIES, INC. EMPLOYEE PROPRIETARY INFORMATION, INVENTIONS, AND NON-COMPETITION AGREEMENT (Filed With SEC on February 25, 2016)
- EMPLOYMENT AGREEMENT (Filed With SEC on February 25, 2016)
- EMPLOYMENT AGREEMENT (Filed With SEC on February 25, 2016)
- EMPLOYMENT AGREEMENT (Filed With SEC on November 5, 2015)
- INTRA-CELLULAR THERAPIES, INC. AMENDED AND RESTATED 2013 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS:AUGUST 23, 2013 AMENDED BY THE BOARDOF DIRECTORS: APRIL 23, 2015... (Filed With SEC on June 18, 2015)
